Cargando…

Measuring frailty in younger populations: a rapid review of evidence

OBJECTIVES: Frailty is typically assessed in older populations. Identifying frailty in adults aged under 60 years may also have value, if it supports the delivery of timely care. We sought to identify how frailty is measured in younger populations, including evidence of the impact on patient outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiers, Gemma F, Kunonga, Tafadzwa Patience, Hall, Alex, Beyer, Fiona, Boulton, Elisabeth, Parker, Stuart, Bower, Peter, Craig, Dawn, Todd, Chris, Hanratty, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986767/
https://www.ncbi.nlm.nih.gov/pubmed/33753447
http://dx.doi.org/10.1136/bmjopen-2020-047051
_version_ 1783668508471590912
author Spiers, Gemma F
Kunonga, Tafadzwa Patience
Hall, Alex
Beyer, Fiona
Boulton, Elisabeth
Parker, Stuart
Bower, Peter
Craig, Dawn
Todd, Chris
Hanratty, Barbara
author_facet Spiers, Gemma F
Kunonga, Tafadzwa Patience
Hall, Alex
Beyer, Fiona
Boulton, Elisabeth
Parker, Stuart
Bower, Peter
Craig, Dawn
Todd, Chris
Hanratty, Barbara
author_sort Spiers, Gemma F
collection PubMed
description OBJECTIVES: Frailty is typically assessed in older populations. Identifying frailty in adults aged under 60 years may also have value, if it supports the delivery of timely care. We sought to identify how frailty is measured in younger populations, including evidence of the impact on patient outcomes and care. DESIGN: A rapid review of primary studies was conducted. DATA SOURCES: Four databases, three sources of grey literature and reference lists of systematic reviews were searched in March 2020. ELIGIBILITY CRITERIA: Eligible studies measured frailty in populations aged under 60 years using experimental or observational designs, published after 2000 in English. DATA EXTRACTION AND SYNTHESIS: Records were screened against review criteria. Study data were extracted with 20% of records checked for accuracy by a second researcher. Data were synthesised using a narrative approach. RESULTS: We identified 268 studies that measured frailty in samples that included people aged under 60 years. Of these, 85 studies reported evidence about measure validity. No measures were identified that were designed and validated to identify frailty exclusively in younger groups. However, in populations that included people aged over and under 60 years, cumulative deficit frailty indices, phenotype measures, the FRAIL Scale, the Liver Frailty Index and the Short Physical Performance Battery all demonstrated predictive validity for mortality and/or hospital admission. Evidence of criterion validity was rare. The extent to which measures possess validity across the younger adult age (18–59 years) spectrum was unclear. There was no evidence about the impact of measuring frailty in younger populations on patient outcomes and care. CONCLUSIONS: Limited evidence suggests that frailty measures have predictive validity in younger populations. Further research is needed to clarify the validity of measures across the adult age spectrum, and explore the utility of measuring frailty in younger groups.
format Online
Article
Text
id pubmed-7986767
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-79867672021-03-29 Measuring frailty in younger populations: a rapid review of evidence Spiers, Gemma F Kunonga, Tafadzwa Patience Hall, Alex Beyer, Fiona Boulton, Elisabeth Parker, Stuart Bower, Peter Craig, Dawn Todd, Chris Hanratty, Barbara BMJ Open Health Policy OBJECTIVES: Frailty is typically assessed in older populations. Identifying frailty in adults aged under 60 years may also have value, if it supports the delivery of timely care. We sought to identify how frailty is measured in younger populations, including evidence of the impact on patient outcomes and care. DESIGN: A rapid review of primary studies was conducted. DATA SOURCES: Four databases, three sources of grey literature and reference lists of systematic reviews were searched in March 2020. ELIGIBILITY CRITERIA: Eligible studies measured frailty in populations aged under 60 years using experimental or observational designs, published after 2000 in English. DATA EXTRACTION AND SYNTHESIS: Records were screened against review criteria. Study data were extracted with 20% of records checked for accuracy by a second researcher. Data were synthesised using a narrative approach. RESULTS: We identified 268 studies that measured frailty in samples that included people aged under 60 years. Of these, 85 studies reported evidence about measure validity. No measures were identified that were designed and validated to identify frailty exclusively in younger groups. However, in populations that included people aged over and under 60 years, cumulative deficit frailty indices, phenotype measures, the FRAIL Scale, the Liver Frailty Index and the Short Physical Performance Battery all demonstrated predictive validity for mortality and/or hospital admission. Evidence of criterion validity was rare. The extent to which measures possess validity across the younger adult age (18–59 years) spectrum was unclear. There was no evidence about the impact of measuring frailty in younger populations on patient outcomes and care. CONCLUSIONS: Limited evidence suggests that frailty measures have predictive validity in younger populations. Further research is needed to clarify the validity of measures across the adult age spectrum, and explore the utility of measuring frailty in younger groups. BMJ Publishing Group 2021-03-22 /pmc/articles/PMC7986767/ /pubmed/33753447 http://dx.doi.org/10.1136/bmjopen-2020-047051 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Health Policy
Spiers, Gemma F
Kunonga, Tafadzwa Patience
Hall, Alex
Beyer, Fiona
Boulton, Elisabeth
Parker, Stuart
Bower, Peter
Craig, Dawn
Todd, Chris
Hanratty, Barbara
Measuring frailty in younger populations: a rapid review of evidence
title Measuring frailty in younger populations: a rapid review of evidence
title_full Measuring frailty in younger populations: a rapid review of evidence
title_fullStr Measuring frailty in younger populations: a rapid review of evidence
title_full_unstemmed Measuring frailty in younger populations: a rapid review of evidence
title_short Measuring frailty in younger populations: a rapid review of evidence
title_sort measuring frailty in younger populations: a rapid review of evidence
topic Health Policy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986767/
https://www.ncbi.nlm.nih.gov/pubmed/33753447
http://dx.doi.org/10.1136/bmjopen-2020-047051
work_keys_str_mv AT spiersgemmaf measuringfrailtyinyoungerpopulationsarapidreviewofevidence
AT kunongatafadzwapatience measuringfrailtyinyoungerpopulationsarapidreviewofevidence
AT hallalex measuringfrailtyinyoungerpopulationsarapidreviewofevidence
AT beyerfiona measuringfrailtyinyoungerpopulationsarapidreviewofevidence
AT boultonelisabeth measuringfrailtyinyoungerpopulationsarapidreviewofevidence
AT parkerstuart measuringfrailtyinyoungerpopulationsarapidreviewofevidence
AT bowerpeter measuringfrailtyinyoungerpopulationsarapidreviewofevidence
AT craigdawn measuringfrailtyinyoungerpopulationsarapidreviewofevidence
AT toddchris measuringfrailtyinyoungerpopulationsarapidreviewofevidence
AT hanrattybarbara measuringfrailtyinyoungerpopulationsarapidreviewofevidence